On the limit of viability extremely low gestational age at birth.
DOI:
https://doi.org/10.20344/amp.1511Abstract
Survival is not an adequate measure of success when managing preterm infants < 24 weeks gestational age (GA).To evaluate neonatal morbidity, survival rate and outcome of preterm infants < 24 weeks GA at birth, in our Neonatal Intensive Care Unit.Retrospective chart review, 1996-2009. Collected data included neonatal morbidity and mortality, follow-up at the outpatient department regarding to medical problems and neurodevelopmental and behavioural outcomes.53 preterm neonates (27 male/ 26 female) were included; weight at birth: 630 g (360-870); gestational age: 23.5 wks (22-24); outborn: 9 (17%); any antenatal steroid: 57%. Neonatal morbidity included: hypotension 68%; respiratory distress syndrome: 98%; pneumothorax: 11%; patent ductus arteriosus: 42%; noso sepsis: 72%; necrotizing enterocolitis (>2A): 54%; intraventricular hemorrhage (III+IV): 34%; retinopathy of prematurity (>2): 20%; bronchopulmonary dysplasia: 71%. Mortality rate was 87% (n = 46). Antenatal steroids rate was 71% and 54%, for survivors and deceased newborns, respectively. Out of the seven (13% of total) survivors aged between 7 months and 14 years old (two under 24 months), five (71%) present major sequelae at the follow-up, while two (29%) exhibit normal “border line” development.Based on these findings it seems that other characteristics of the infants and pregnancies, and not gestational age alone, should be considered before a decision is taken.Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.